bgb-3245
bergenbio
['bgb-3245', 'bgb-324']
taking place now at #aacr23: is presenting data from a first-in-human study of the raf dimer inhibitor bgb-3245 in people with advanced or refractory tumors. her presentation is in the chapin theater. 
The official account of @MSKCancerCenter’s Department of Medicine. Chair/Dept. Head: @debschrag